Lead global cross-function, cross-region teams to develop and deploy global brand strategy and commercialization plans for assets in therapeutic areas of cognition and anti-infectious disease, from proof of concept through life cycle management stages.Lead the Global Commercial Matrix Team (GCMT) to develop and implement key global commercial strategy and activities including but not limited to: global brand plan, global forecast, customer insights and segmentation, global branding, global positioning and communications plan, key messages, LCM plan, and associated budgets.Responsible for interactions with senior management and obtaining necessary endorsement from global commercial decision-making bodies for key commercial decisions.Provide integrated, global commercial input into the Global Development Plan, clinical development plans and other key decisions. Accountable for ensuring patient, physician and payer unmet needs and insights are incorporated into the clinical development plans and the overall Global Development Plans to ensure commercial success across all major markets.Obtain feedback and drive consensus among key stakeholders on key commercial decisions, including payer/reimbursement, health outcomes, clinical, regulatory, and project management.Develop, deploy commercial excellence and strategic planning programs to enhance global brand planning process.

Led global brand ($0.5B OTC franchise) by developing and nurturing distinctive, consistent brand vision, strategy, positioning, portfolio, and pipeline.

Directed $200M China Wellness portfolio strategy, long-term pipeline development, and in-market execution of strategic initiatives.

Managed P&L for four brands (FiberChoice, Beano, TUMS, OsCal). Annual Sales from $30 - $175MM.

Commercial Lead for US Rx-OTC Switch launch preparation for Respiratory and Dermatology brands, with annual Sales forecast of >$100MM.